Inherited complement deficiencies.
Isolated genetic deficiencies of individual components of the complementary system have been described in man for all the components of the classical pathway and the membrane attack complex as well as for Factor I, Factor H and properdin. It is only for Factor B and Factor D of the alternative pathway that homozygous deficiency states are not so far known. Complement deficiency states provide the most direct way of looking at the role of the complement system in vivo and emphasize the importance of complement in resistance to bacterial infection and in particular to infection with Neisseria. This association is not unexpected since in vitro studies have shown complement to be an efficient enhancer of phagocytosis and inflammation. The particularly frequent occurrence of neisserial infection may be ascribed to the ability of these organisms to survive in phagocytic cells so that the plasma cytolytic activity provided by complement is needed to kill them. On the other hand the strong association between complement deficiencies and immune-complex diseases--especially systemic lupus erythematosus--was unexpected and seems paradoxical in view of the large part played by complement in the pathogenesis of immune complex mediated tissue damage. The paradox can be explained in part by the necessity for an intact complement system in the solubilization and the proper handling of immune complexes. It is also likely that complement deficiency can allow the persistence of low virulence organisms that produce disease solely by an immune complex mechanism. Recently described deficiencies of complement receptors and their effects in vivo are described.
D001782:Blood Donors; D003174:Complement C1 Inactivator Proteins / Q000172:deficiency; D003183:Complement C6 / Q000172:deficiency; D003184:Complement C7 / Q000172:deficiency; D003185:Complement C8 / Q000172:deficiency; D015938:Complement Membrane Attack Complex; D003165:Complement System Proteins / Q000172:deficiency* / Q000235:genetics; D006461:Hemolysis; D006801:Humans; D007105:Immune Complex Diseases / Q000150:complications; D007153:Immunologic Deficiency Syndromes / Q000453:epidemiology / Q000235:genetics*; D008180:Lupus Erythematosus, Systemic / Q000276:immunology; D008589:Meningococcal Infections / Q000209:etiology; D011951:Receptors, Complement / Q000172:deficiency / Q000502:physiology; D017463:Receptors, Complement 3b
D003174:Complement C1 Inactivator Proteins; D003183:Complement C6; D003184:Complement C7; D003185:Complement C8; D015938:Complement Membrane Attack Complex; D011951:Receptors, Complement; D017463:Receptors, Complement 3b; D003165:Complement System Proteins